Medtronic penalised $22M over sale of bone graft kits without regulatory OK
Healthcare 2024-09-20 11:32 pm By Andy Sidler | Melbourne
Please login to bookmark Close

Medical device supplier Medtronic has been socked with a $22 million penalty after it supplied non-compliant bone graft kits to hospitals, in what is the largest penalty under the Therapeutics Good Act.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au